Michael Garren, MD (@MichaelGarrenMD) header
Michael Garren, MD (@MichaelGarrenMD) profile picture

MIS/ Bariatric Surgeon at University of Wisconsin. Views expressed are my own.

Madison, WI
Joined December 2012
Michael Garren, MD retweeted
It is hard to imagine that cutting away a portion of the stomach could prevent future Alzheimer’s Disease but here, in our first of many stories to come, we show just that! SG’s effects on the brain are profound and long lasting! @LammingLab @WiscSurgery onlinelibrary.wiley.com/doi/…
4
1
9
1,324
Michael Garren, MD retweeted
We are beyond excited to welcome @Kayla_Councell and @lindsaygil6 as the 2027 #MIS/#bari/#foregut and #Hernia fellows! Welcome to @WiscSurgery and to the best MIS family around! #onWisconsin @uchicagosurgery @OhioStateSurg @FellowshpCouncl
3
7
240
Age and Visceral Fat May Trend Together: What to Know medscape.com/viewarticle/age… @WiscSurgery
1
51
Michael Garren, MD retweeted
The announcement from @UWHealth
Two iconic Wisconsin brands. One remarkable team. We’re proud to be the Official Health Care Partner of the @Packers
1
5
118
21,651
Michael Garren, MD retweeted
GLP-1s won’t replace surgery—but they’re changing how, when, and who we operate on. Experts outline a hybrid future for obesity care at #ACSCC2025 🔗 generalsurgerynews.com/a/ADU… #GLP1
1
3
224
Michael Garren, MD retweeted
Among US adults with class II/III #obesity, bariatric surgery was associated with greater weight loss and lower costs than #GLP-1 receptor agonists, with GLP-1 therapy initiated in 1 in 10 post-surgical patients. Watch the video and learn more in these JAMA Surgery studies: ⬇️
2
24
3
152
8,789
Cancer Before 40: Michelle Robinson Story youtu.be/-27gdcp1CZI?si=iPiT… via @YouTube A powerful story of the value of bariatric surgery and dealing with a cancer diagnosis. @UWHealth
1
2
170
Cardiovascular Outcomes and Mortality of Bariatric Surgery versus Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-analysis - Surgery for Obesity and Related Diseases soard.org/article/S1550-7289…
47
Michael Garren, MD retweeted
GLP-1s are changing obesity care—but surgery is still the gold standard. #ACSCC2025 experts say surgical treatment offers greater, longer-lasting results for many patients. Read more: generalsurgerynews.com/a/zjM… #BariatricSurgery #ObesityCare #GLP1
1
368
Michael Garren, MD retweeted
Bariatric surgery was associated with more effective, durable treatment of class II and III obesity at lower costs than #GLP1 receptor agonists. ja.ma/49H4o1p
2
47
3
118
13,101
Just want to see some pride Badgers!
75
Michael Garren, MD retweeted
"What we as a culture have to get back to is being able to have reasonable disagreement—where violence is not an option." — Charlie Kirk.
2
36
2
90
3,800
We are beyond thrilled to welcome Drs. Cameron Casson @WashUSurgery (#AbWall) and Yatee Dave @URMCSurgery (#Foregut #Bariatrics) to @WiscSurgery MIS!!
8
20
947